Patents by Inventor Helmut Lietz

Helmut Lietz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antineoplastic peptides
    Patent number: 8440626
    Abstract: The present invention provides antineoplastic peptides of formula I, I R1R2N-CHX-CO-A-B-D-E-(G)S-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: May 14, 2013
    Assignee: Abbott GmbH & Co. KG
    Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
  • ANTINEOPLASTIC PEPTIDES
    Publication number: 20110098235
    Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N-CHX-CO-A-B-D-E-(G)S-K?I wherein R1, R2, X, A, B, D, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.
    Type: Application
    Filed: August 26, 2010
    Publication date: April 28, 2011
    Applicant: ABBOTT GMBH & CO. KG
    Inventors: Wilhelm AMBERG, Teresa BARLOZZARI, Harald BERNARD, Ernst BUSCHMANN, Andreas HAUPT, Hans-Guenther HEGE, Bernd JANSSEN, Andreas KLING, Helmut LIETZ, Kurt RITTER, Martina ULLRICH, Jürgen WEYMANN, Thomas ZIERKE
  • Antineoplastic peptides
    Patent number: 7807779
    Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO—A—B-D-E-(G)s-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: October 5, 2010
    Assignee: Abbott GmbH & Co. KG
    Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
  • Antineoplastic peptides
    Publication number: 20080234205
    Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO—A—B-D-E-(G)s-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.
    Type: Application
    Filed: March 31, 2008
    Publication date: September 25, 2008
    Applicant: Abbott GmbH & Co. KG
    Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
  • Antineoplastic peptides
    Patent number: 7368528
    Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO-A-B-D-E-(G)s-K I wherein R1, R2, X, A, B, D, E, G, K, and s have the meanings stated in the description. The compounds have antineoplastic activity.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: May 6, 2008
    Assignee: Abbott GmbH & Co. KG
    Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weyman, Thomas Zierke
  • Antineoplastic peptides
    Publication number: 20060009392
    Abstract: The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO-A-B-D-E-(G)s-K ??I wherein R1, R2, X, A, B, D, E, G, K, and s have the meanings stated in the description. The compounds have antineoplastic activity.
    Type: Application
    Filed: July 11, 2005
    Publication date: January 12, 2006
    Applicant: Abbott GMBH & Co., KG.
    Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
  • Antineoplastic peptides
    Publication number: 20010009901
    Abstract: The present invention provides antineoplastic peptides of formula I,
    Type: Application
    Filed: January 9, 2001
    Publication date: July 26, 2001
    Applicant: BASF Aktiengesellschaft Germany
    Inventors: Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Andreas Haupt, Hans-Guenther Hege, Bernd Janssen, Andreas Kling, Helmut Lietz, Kurt Ritter, Martina Ullrich, Jurgen Weymann, Thomas Zierke
  • Aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones, their preparation and therapeutic agents containing these compounds
    Patent number: 4571409
    Abstract: Novel aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones and their physiologically acceptable acid addition compounds, processes for their preparation and therapeutic agents which contain these derivatives and are useful as antiarrhythmic drugs.
    Type: Grant
    Filed: May 13, 1985
    Date of Patent: February 18, 1986
    Assignee: BASF Aktiengesellschaft
    Inventors: Albrecht Franke, Josef Mueller, Helmut Lietz, Walter-Wielant Wiersdorff, Hans-Guenther Hege, Claus D. Mueller, Josef Gries, Dieter Lenke, Gerda von Philipsborn, Manfred Raschack
  • Aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones, pharmaceutical compositions and use
    Patent number: 4540697
    Abstract: Novel aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones and their physiologically acceptable acid addition compounds, processes for their preparation and therapeutic agents which contain these derivatives and are useful as antiarrhythmic drugs.
    Type: Grant
    Filed: May 23, 1984
    Date of Patent: September 10, 1985
    Assignee: BASF Aktiengesellschaft
    Inventors: Albrecht Franke, Josef Muller, Helmut Lietz, Walter-Wielant Wiersdorff, Hans-Gunther Hege, Claus D. Muller, Josef Gries, Dieter Lenke, Gerda von Philipsborn, Manfred Raschack
  • Preparation of propafenone
    Patent number: 4474986
    Abstract: A process for the preparation of propafenone wherein1. 2'-hydroxyacetophenone is reacted with epichlorohydrin,2. the resulting 2-(2',3'-epoxypropoxy)-acetophenone is reacted with propylamine,3. the resulting 2-(2'-hydroxy-3'-propylaminopropoxy)-acetophenone is reacted with benzaldehyde, accompanied by elimination of water, and4. the resulting 2-(2'-hydroxy-3'-propylaminopropoxy)-benzalacetophenone is hydrogenated.
    Type: Grant
    Filed: March 18, 1983
    Date of Patent: October 2, 1984
    Assignee: BASF Aktiengesellschaft
    Inventor: Helmut Lietz